Attention subscribers
-
Already a subscriber but can’t log in? Click here to locate your subscription and set up online access.
If you’ve tried this and still can’t sign in, contact your local office or email info@richardsonmediagroup.net.
If you’ve tried this and still can’t sign in, contact your local office or email info@richardsonmediagroup.net.
DEA Increases Production Quota to Manufacture Medication to Treat Attention Deficit Disorder
Posted 10/2/23
Adjustment to the Aggregate Production Quota for Methylphenidate (for Sale) for 2023 DEA Increases Production Quota to Manufacture Medication to Treat Attention Deficit Disorder To address shortages …
This item is available in full to subscribers.
Attention subscribers
To continue reading, you will need to either log in to your subscriber account, below, or purchase a new subscription.
Please log in to continue |